Giulia Biagioni

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy

I. Olivotto, F. Cecchi, A. Tomberli, 2023, Journal of clinical medicine.

The evolving paradigm and current perception of hypertrophic cardiomyopathy: Implications for management.

I. Olivotto, A. Tomberli, M. Zampieri, 2023, Progress in cardiovascular diseases.

Serial changes in CPET parameters in untreated patients with transthyretin cardiac amyloidosis.

C. Mazzoni, S. Baldasseroni, C. Burgisser, 2023, The Canadian journal of cardiology.

Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies

I. Olivotto, A. Guaricci, M. Ciabatti, 2024, JACC. Advances.

Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

C. Autore, G. Sinagra, F. Re, 2023, European journal of heart failure.